FDA Drug Application (062655) for TAZIDIME by LILLY

Back to FDA Applications sponsored by LILLY

Application Number062655
Product Number001
FormINJECTABLE;INJECTION
Dosage1GM/VIAL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTAZIDIME
Active IngredientCEFTAZIDIME

Active IngredientCount
List of drugs with Active Ingredient CEFTAZIDIME9


Back to FDA Applications sponsored by LILLY